Identifying Nanobiotechnology Based Solutions for Opportunities in Personalized Healthcare

During this webinar, Joshua Smith and Stacey Gifford from IBM’s Nanobiotechnology Program provide an overview of the latest research on the relevant biology found in fluids from liquid biopsies. In addition, Smith and Gifford discuss opportunities in microfluidics for disruptive technology development to isolate and interrogate these biomarkers, aiding disease diagnosis, prognosis, and treatment-response monitoring. This webinar was recorded on November 15, 2018 and runs 01:02:33 minutes in length.